Beyond the numbers : An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses
Copyright © 2023. Published by Elsevier Ltd..
BACKGROUND: Cameroon has been struggling with low Covid-19 vaccination coverage, with only 4.5 % of the population receiving the primary series as of November 2022. The COVID-19 Vaccine Delivery Partnership (CoVDP) conducted a high-level mission to Cameroon to assess progress and advocate for actions to address bottlenecks. The objective of the mission was to administer at least 3,000,000 doses of vaccines during the 5th Mass vaccination campaign. This study examines the factors contributing to the success of the campaign and uses a geographical and gender lens to assess the results.
METHODS: The study is a secondary analysis of data from the DHIS2 collected during the 5th mass vaccination campaign for Covid-19. Descriptive statistics were used to assess coverages per location and gender expressed in OR. sccess factors, and chi-squared tests were used to assess differences in vaccine distribution across regions and by gender.
RESULTS: This 5th vaccination campaign benefitted from a strong political commitment facilitated by CoVDP's mission, international support, collaboration, planning, supervision, and demand generation. The campaign recorded 2 019 118 administered vaccine doses, a staggering 46-fold increase in vaccinated individuals relative to the first round, with vaccination coverage reaching 10.1 % of the general population. However, the study reveals regional and gender disparities in vaccination coverage. Men had higher odds of being vaccinated than women in the three Sahel regions. Among individuals with comorbidities, the national coverage rate was only 14 %, and the Far North and East regions exhibited the lowest coverage rates. Janssen was the most used vaccine, and the total AEFI cases reported were 2 per 1000 vaccine doses.
CONCLUSION: The 5th COVID-19 vaccination campaign in Cameroon saw a strong political commitment and was the most successful so far. Despite the gains, there was gender disparity in coverage in some regions. It is important to continue the established momentum, ensure equitable access in the Sahel regions, and reach high-priority groups with primary series and booster doses.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Vaccine - 41(2023), 38 vom: 31. Aug., Seite 5572-5579 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Amani, Adidja [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 14.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.vaccine.2023.07.062 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360244556 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360244556 | ||
| 003 | DE-627 | ||
| 005 | 20231227131430.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.vaccine.2023.07.062 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM360244556 | ||
| 035 | |a (NLM)37524630 | ||
| 035 | |a (PII)S0264-410X(23)00905-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Amani, Adidja |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Beyond the numbers |b An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 14.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier Ltd. | ||
| 520 | |a BACKGROUND: Cameroon has been struggling with low Covid-19 vaccination coverage, with only 4.5 % of the population receiving the primary series as of November 2022. The COVID-19 Vaccine Delivery Partnership (CoVDP) conducted a high-level mission to Cameroon to assess progress and advocate for actions to address bottlenecks. The objective of the mission was to administer at least 3,000,000 doses of vaccines during the 5th Mass vaccination campaign. This study examines the factors contributing to the success of the campaign and uses a geographical and gender lens to assess the results | ||
| 520 | |a METHODS: The study is a secondary analysis of data from the DHIS2 collected during the 5th mass vaccination campaign for Covid-19. Descriptive statistics were used to assess coverages per location and gender expressed in OR. sccess factors, and chi-squared tests were used to assess differences in vaccine distribution across regions and by gender | ||
| 520 | |a RESULTS: This 5th vaccination campaign benefitted from a strong political commitment facilitated by CoVDP's mission, international support, collaboration, planning, supervision, and demand generation. The campaign recorded 2 019 118 administered vaccine doses, a staggering 46-fold increase in vaccinated individuals relative to the first round, with vaccination coverage reaching 10.1 % of the general population. However, the study reveals regional and gender disparities in vaccination coverage. Men had higher odds of being vaccinated than women in the three Sahel regions. Among individuals with comorbidities, the national coverage rate was only 14 %, and the Far North and East regions exhibited the lowest coverage rates. Janssen was the most used vaccine, and the total AEFI cases reported were 2 per 1000 vaccine doses | ||
| 520 | |a CONCLUSION: The 5th COVID-19 vaccination campaign in Cameroon saw a strong political commitment and was the most successful so far. Despite the gains, there was gender disparity in coverage in some regions. It is important to continue the established momentum, ensure equitable access in the Sahel regions, and reach high-priority groups with primary series and booster doses | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 vaccination | |
| 650 | 4 | |a Cameroon | |
| 650 | 4 | |a CoVDP | |
| 650 | 4 | |a Gender and geographical analysis | |
| 650 | 4 | |a High-risk groups | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Njoh, Andreas Ateke |e verfasserin |4 aut | |
| 700 | 1 | |a Atuhebwe, Phionah |e verfasserin |4 aut | |
| 700 | 1 | |a Ndoula, Shalom |e verfasserin |4 aut | |
| 700 | 1 | |a Nembot, Raoul |e verfasserin |4 aut | |
| 700 | 1 | |a Mbossou, Franck |e verfasserin |4 aut | |
| 700 | 1 | |a Tsague, Landry |e verfasserin |4 aut | |
| 700 | 1 | |a Adisso, Lionel |e verfasserin |4 aut | |
| 700 | 1 | |a Bita Fouda, André Arsène |e verfasserin |4 aut | |
| 700 | 1 | |a Gonese, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Perrault, Nadine |e verfasserin |4 aut | |
| 700 | 1 | |a Habimana, Phanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Saidu, Yauba |e verfasserin |4 aut | |
| 700 | 1 | |a Mirza, Imran |e verfasserin |4 aut | |
| 700 | 1 | |a Ntakarutimana, Donatien |e verfasserin |4 aut | |
| 700 | 1 | |a Balde, Thierno |e verfasserin |4 aut | |
| 700 | 1 | |a Mihigo, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Chaiban, Ted |e verfasserin |4 aut | |
| 700 | 1 | |a Gueye, Abdou Salam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vaccine |d 1985 |g 41(2023), 38 vom: 31. Aug., Seite 5572-5579 |w (DE-627)NLM012600105 |x 1873-2518 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2023 |g number:38 |g day:31 |g month:08 |g pages:5572-5579 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vaccine.2023.07.062 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2023 |e 38 |b 31 |c 08 |h 5572-5579 | ||